BiomimX Efficacy Study for Therapeutics targeting Osteoarthritis

BiomimX recently collaborated with a biotech company on an efficacy study for a novel therapeutic product targeting osteoarthritis. 

The results of this study will soon be published in Advanced Healthcare Materials and have been accepted by Swedish regulatory authorities as part of an Investigational New Drug (IND) application, paving the way for clinical trials in phases 1 and 2a.